Cargando…

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma

BACKGROUND: Glioma is an incurable malignant lesion with poor outcome characterized by easy recurrence after surgery with or without radiotherapy and chemotherapy. Studies have shown that COL6A2 is closely related to the tumorigenesis and development of a variety of tumors. However, the role of COL6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jinchao, Lin, Qingyuan, Zheng, Haiyan, Rao, Yamin, Ji, Tianhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732579/ https://www.ncbi.nlm.nih.gov/pubmed/36505882 http://dx.doi.org/10.3389/fonc.2022.897042

Ejemplares similares

Cell origin and genome profile difference of penoscrotum invasive extramammary Paget disease compared with its in situ counterpart
por: Rao, Yamin, et al.
Publicado: (2022)

A novel melanoma prognostic model based on the ferroptosis-related long non-coding RNA
por: Rao, Yamin, et al.
Publicado: (2022)

A-Kinase Interacting Protein 1 Knockdown Restores Chemosensitivity via Inactivating PI3K/AKT and β-Catenin Pathways in Anaplastic Thyroid Carcinoma
por: Zheng, Haiyan, et al.
Publicado: (2022)

COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas
por: Gu, Sujie, et al.
Publicado: (2021)

Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma
por: Ma, Yi, et al.
Publicado: (2021)

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer
por: Zhu, Zheng, et al.
Publicado: (2022)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
por: Yang, Lewei, et al.
Publicado: (2022)

Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma
por: Liu, Junhui, et al.
Publicado: (2021)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

MiR-29b-3p Inhibits Migration and Invasion of Papillary Thyroid Carcinoma by Downregulating COL1A1 and COL5A1
por: Wang, Congjun, et al.
Publicado: (2022)

AMPD1 Is Associated With the Immune Response and Serves as a Prognostic Marker in HER2-Positive Breast Cancer
por: Wang, Long, et al.
Publicado: (2021)

DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker
por: Zhang, Jingwen, et al.
Publicado: (2021)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
por: Xie, Qijun, et al.
Publicado: (2022)

High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker
por: Papadakos, Konstantinos S., et al.
Publicado: (2019)

Novel applications of histopathological markers to distinguish prognostic subgroups in colorectal adenocarcinoma
por: Yuan, Yuan, et al.
Publicado: (2023)

A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells
por: Huang, Shenq-Shyang, et al.
Publicado: (2021)

Sirtuin 7 promotes glioma proliferation and invasion through activation of the ERK/STAT3 signaling pathway
por: Mu, Pengfei, et al.
Publicado: (2019)

Corrigendum: A Novel Invadopodia-Specific Marker for Invasive and Pro-Metastatic Cancer Stem Cells
por: Huang, Shenq-Shyang, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas
por: Liu, Yi, et al.
Publicado: (2022)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Overexpression of p16(INK4a) Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated With Radiotherapy Irrespective of HPV-Status
por: Arians, Nathalie, et al.
Publicado: (2019)

Molecular Pathological Markers Correlated With the Recurrence Patterns of Glioma
por: Ge, Shunnan, et al.
Publicado: (2021)

Prefoldin subunits (PFDN1–6) serve as poor prognostic markers in gastric cancer
por: Yesseyeva, Galiya, et al.
Publicado: (2020)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

GCN5 Potentiates Glioma Proliferation and Invasion via STAT3 and AKT Signaling Pathways
por: Liu, Kun, et al.
Publicado: (2015)

RGS16 promotes glioma progression and serves as a prognostic factor
por: Huang, Ruoyu, et al.
Publicado: (2020)

Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020)

Prognostication in palliative radiotherapy—ProPaRT: Accuracy of prognostic scores
por: Maltoni, Marco, et al.
Publicado: (2022)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Transmembrane protein 88 suppresses hepatocellular carcinoma progression and serves as a novel prognostic factor
por: Cai, Lin, et al.
Publicado: (2023)

Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer
por: Deng, Lin, et al.
Publicado: (2020)

NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma
por: Han, Yan-Long, et al.
Publicado: (2022)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

OSlgg: An Online Prognostic Biomarker Analysis Tool for Low-Grade Glioma
por: An, Yang, et al.
Publicado: (2020)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f2qi8v81m3tjqg7oo7a512rbho